RxDoctor Payments Data

James Richard, PA

Physician Assistant · Cumberland, NCNPI 1467779322

Payments from drug & device makers

$577in general payments, 2019–2025

Across 21 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$254
  • Bayer$82
  • Novo Nordisk$75
  • Lilly USA, LLC$62
  • Baxter Healthcare$42
  • Sanofi-aventis U.S. LLC$27
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$577100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$577 in reported general payments places this provider in the 60th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$56,134
Medicare patients
244
Services billed
971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin19$20,373
OzempicSemaglutide13$20,228
JanumetSitagliptin Phos/Metformin Hcl15$11,386
LinzessLinaclotide11$5,952
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen125$4,175
Albuterol Sulfate HfaAlbuterol Sulfate39$1,717
Gabapentin98$1,549
Paroxetine ErParoxetine Hcl11$1,526
Rosuvastatin Calcium124$1,456
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,333
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$1,318
Nystatin54$1,270
Fentanyl13$1,213
Atorvastatin Calcium110$1,097
Fluticasone Propionate64$1,044

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$75$20,22813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Cumberland

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →